Clinical Genomics Bioinformatics Vendor Security Risk Assessment Checklist

Kevin Henry

Risk Management

Published Updated

10 minutes read
Share this article
Clinical Genomics Bioinformatics Vendor Security Risk Assessment Checklist

Clinical genomics vendors may handle protected health information (PHI), sequencing files, clinical interpretations, and other data that could identify patients. Use this checklist to examine how a vendor protects those data across its people, systems, services, and subcontractors.

Ask for evidence and confirm that each safeguard covers the specific service you plan to use. A policy, questionnaire, or security certificate alone does not establish that the vendor’s controls are effective for your data and workflow.

How to assess a vendor’s security governance and risk management

Start by understanding who is accountable for security, how the vendor identifies risks, and how it follows through on remediation. Ask for its current security policies, a summary of its risk assessment, and evidence of independent testing or audits. The HIPAA Security Rule requires regulated entities to conduct a risk analysis and manage identified risks to electronic PHI; a vendor’s documentation can help you evaluate its safeguards and your own obligations. See HHS guidance on HIPAA risk analysis and risk management.

  • Identify the security and privacy leaders, escalation contacts, and responsibilities for the service.
  • Review the scope, date, findings, and remediation status of independent assessments, penetration tests, or audits. Ask what systems and services were included.
  • Request a risk-management process showing how risks are recorded, prioritized, assigned, and tracked to resolution.
  • Confirm that security policies cover workforce training, acceptable use, data handling, retention, secure development, and termination of access.
  • Ask how the vendor evaluates and monitors cloud providers, sequencing platforms, analytics services, and other subcontractors that may handle your data.
  • Check whether the vendor can provide timely notice of material changes to its controls, services, or subcontractors.

For subprocessor risk management, request a list of relevant subprocessors, the services they perform, the data they may access, and the safeguards and contractual requirements that apply to them. HIPAA business associates must obtain appropriate written assurances from subcontractors that handle electronic PHI. HHS’s HIPAA Security Rule summary describes this obligation.

What data protection controls safeguard genomic and clinical data

Map the data lifecycle: collection, transfer, analysis, storage, sharing, backup, retention, and destruction. Ask the vendor to distinguish direct identifiers, clinical records, genomic files, derived results, and research datasets, and to explain which teams and systems can access each category.

  • Encryption at rest and in transit: Ask what encryption protects production data, backups, temporary files, and transfers; how keys are managed; and how access to keys is restricted and logged. HIPAA treats encryption as an addressable implementation specification: the regulated entity must assess whether it is reasonable and appropriate and document its decision. See HHS guidance on encryption under the Security Rule.
  • Data separation: Confirm how the vendor separates your organization’s data from other customers’ data and prevents cross-tenant access.
  • Data minimization: Ask whether the vendor can limit collection, processing, and retention to what the service needs.
  • Backups and deletion: Review backup protection, recovery testing, retention periods, and how the vendor verifies return or secure destruction when the service ends.
  • Use restrictions: Confirm whether the vendor may use data for product development, analytics, or model training, and whether any such use requires your authorization or a separate agreement.

Do not assume that genomic data are anonymous simply because names and medical-record numbers have been removed. HIPAA recognizes formal expert determination and removal of specified identifiers as de-identification methods, while noting that some re-identification risk may remain. Ask the vendor to explain its genomic data de-identification method, the data elements retained, and controls against linkage or re-identification. See HHS guidance on HIPAA de-identification.

How to evaluate access controls and identity management

Review how the vendor grants, monitors, and revokes access for employees, contractors, administrators, and customer users. Access should align with each person’s job and be limited to the data and functions needed for that work.

  • Ask whether the service supports unique user accounts, strong authentication, and multifactor authentication, especially for privileged and remote access.
  • Review its role-based access control model, including how roles are defined, approved, reviewed, and updated.
  • Confirm that administrative access is restricted, logged, and reviewed, and ask how emergency or elevated access is controlled.
  • Ask how quickly accounts are disabled when a worker changes roles or leaves, and how access is reviewed periodically.
  • Check whether audit logs capture access to records, exports, administrative actions, and changes to permissions, and how long those logs are retained.
  • Establish how your organization’s identity provider, single sign-on, and user-provisioning processes fit with the vendor’s controls.

Make responsibilities explicit: some controls may be operated by your organization, the vendor, or both. HHS notes that security responsibilities can depend on the service arrangement, risk-management plans, and contract terms. HHS guidance on HIPAA and cloud computing discusses this shared-responsibility issue.

Ready to assess your HIPAA security risks?

Join thousands of organizations that use Accountable to identify and fix their security gaps.

Take the Free Risk Assessment

What to review in infrastructure security and vulnerability management

Ask for a clear description of where data are hosted and how the vendor protects the underlying infrastructure, applications, networks, and endpoints. Evaluate the controls that apply to the actual service—not only the vendor’s corporate network.

  • Review system boundaries, hosting locations, cloud dependencies, data flows, and separation between development, testing, and production environments.
  • Ask how the vendor discovers, prioritizes, patches, and verifies vulnerabilities in operating systems, applications, libraries, containers, and connected services.
  • Request a recent penetration-test summary and remediation evidence for material findings; clarify whether testing covered the service and its interfaces.
  • Review secure-development practices, including code review, dependency management, change approval, and testing before production release.
  • Ask how the vendor monitors systems, protects logs, detects suspicious activity, and maintains resilient, tested backups.
  • Confirm whether the vendor tracks security risks from suppliers and subcontractors throughout the relationship.

Use the vendor’s answers to identify gaps, assign owners, and set review dates. NIST describes a risk-based framework that integrates security, privacy, and cybersecurity supply-chain risk management into the system life cycle. See the NIST Risk Management Framework.

How to assess incident response and breach notification procedures

Ask the vendor for its incident-response plan and a clear explanation of how it detects, investigates, contains, and documents incidents involving your data. Confirm that the plan covers unauthorized access, ransomware, lost devices, compromised credentials, and incidents at subprocessors.

  • Identify the contacts and channels for urgent incident communications, including after-hours escalation.
  • Review how the vendor preserves evidence, assesses the data and individuals affected, contains the incident, and supports investigation and recovery.
  • Ask what information its first notice will include, how often it will provide updates, and how it will deliver a final incident report.
  • Confirm that the vendor will coordinate with you on regulatory, patient, and other notifications, and clarify which party is responsible for each action.
  • Review how the vendor documents incidents and applies lessons learned, including corrective actions and testing of its response plan.

For HIPAA business associates, the agreement must address reporting security incidents, and the Breach Notification Rule requires a business associate to notify the covered entity of a breach of unsecured PHI without unreasonable delay and no later than 60 days after discovery. That outer limit is not a recommended target for a customer’s operational notice deadline: negotiate a shorter contractual timeframe that gives you time to investigate and meet your own obligations. See HHS guidance on security-incident reporting by cloud service providers and the HHS Breach Notification Rule.

Which privacy and regulatory obligations apply to clinical genomics vendors

Determine which laws apply based on the parties, data, service, and purpose—not just the vendor’s industry label. Genetic information can be PHI under HIPAA when it is individually identifiable health information held by a covered entity or business associate. A vendor handling PHI on behalf of a covered entity may have business associate obligations; the parties should assess their roles and document them. See HHS guidance on genetic information and PHI.

If the vendor is your business associate, review the HIPAA business associate agreement alongside the service contract. Confirm that the BAA defines permitted uses and disclosures, requires appropriate safeguards, addresses subcontractors, requires incident and breach reporting, and explains return or destruction of PHI when the relationship ends. HHS provides a summary of required business associate contract provisions.

HIPAA is not the only possible obligation. Depending on the service and context, assess applicable state privacy and breach-notification laws, research protections, laboratory requirements, and other rules governing the test, software, or intended use. Ask the vendor to identify the obligations it believes apply and have qualified counsel confirm the allocation of responsibilities. A BAA or security assessment does not, by itself, resolve every privacy or regulatory requirement.

Conclusion

Assess the vendor across governance, data protection, access, infrastructure, incident response, and applicable obligations. Verify evidence for the specific service, document shared responsibilities, and use the contract to set clear safeguards, subcontractor requirements, and incident-notification timelines.

FAQs.

What security documentation should a clinical genomics vendor provide?

Request security policies, a summary of the vendor’s risk assessment and remediation process, relevant independent audit or assessment reports, penetration-test summaries, incident-response procedures, data-flow and hosting details, and a list of subprocessors. The HIPAA Rules do not generally require a vendor to provide its customers with security documentation or permit customer audits; customers may seek these assurances through the BAA, service agreement, or other documentation based on their risk assessment. See HHS guidance on customer requests for cloud-provider security documentation.

How should a vendor protect genomic data in transit and at rest?

Evaluate encryption for transfers, production storage, backups, and temporary files; ask how encryption keys are protected and who can access them. Also assess access restrictions, logging, data separation, and safeguards for exports and analysis environments. Under HIPAA, encryption is an addressable Security Rule specification, so regulated entities must assess whether it is reasonable and appropriate and document their decision. HHS explains the encryption requirement.

What should a HIPAA business associate agreement cover for genomic data?

The BAA should specify permitted and required uses and disclosures, require safeguards for PHI, address subcontractors, require reporting of security incidents and breaches, and explain how PHI will be returned or destroyed when feasible at the end of the relationship. It should also clarify operational details such as incident contacts, information-sharing expectations, and any shorter notice deadlines the parties agree to. See HHS’s summary of business associate agreement provisions.

How quickly should a vendor notify customers after a security incident?

Agree on a prompt contractual deadline suited to the incident’s severity and the time you need to investigate and meet applicable obligations. For a HIPAA business associate, the federal rule requires notification of a breach of unsecured PHI without unreasonable delay and no later than 60 days after discovery; that is a maximum, not a recommended customer-notification target. Security incidents that do not meet the definition of a reportable breach are addressed separately, so the BAA should clearly define reporting expectations for them as well. See HHS guidance on incident reporting and BAAs.

Share this article

Ready to assess your HIPAA security risks?

Join thousands of organizations that use Accountable to identify and fix their security gaps.

Take the Free Risk Assessment

Related Articles